G83R基因突变对氨酸蛋白结构稳定性的影响
Xingwang Chen1,2,3,4,5, Junlin Pan2,3,4,5, Xiaomei Nie1,6
1Suzhou Medical College, Soochow University, Suzhou 215021, China.
ACS omega
|September 2, 2025
概括
转基因G83R突变破坏了TTR蛋白质的结构和动态,增加了粉样纤维的形成. 这项研究阐明了与TTR相关的玻璃性粉症的致病机制.
科学领域:
- 生物化学
- 结构生物学
- 分子遗传学
背景情况:
- 转氨酸 (TTR) G83R突变与玻璃性粉症和视力损伤有关.
- 了解G83R对TTR结构和稳定性的影响对于阐明疾病的发病性至关重要.
研究的目的:
- 调查TTR G83R的热力学和动态稳定性.
- 将TTR G83R的纤维形成与野生型TTR和V30M变体进行比较.
- 阐明TTR G83R相关的粉症的分子机制.
主要方法:
- 使用NetSurfP 3.0,DynaMut2和Desmond进行生物信息学分析.
- 尿素介导的变性和光光谱 (三聚和白醇).
- 在酸性条件下的分子动力学模拟和纤维形成的评估.
主要成果:
- 通过增加分子灵活性,G83R突变减少了TTR的动态稳定性.
- TTR G83R的热力学稳定性低于野生型,但高于V30M.
- 在酸性条件下,TTR G83R的纤维形成率介于野生类型和V30M之间.
结论:
- G83R突变显著降低了TTR的热力学和动态稳定性.
- G83R促进了TTR四聚合物解聚,并加速了粉样纤维的形成.
- 这些发现为与TTR相关的粉样蛋白病变提供了洞察力.
更多相关视频
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
492
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
8.4K
相关概念视频
Translation
15.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
15.5K
Protein Folding Quality Check in the RER
3.8K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.8K
Mutations
84.2K
Overview
84.2K
Protein Modifications in the RER
5.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
